Amarin Corporation PLC Reports Third Quarter 2012 Financial Results and Provides Update on Operations

Published: Nov 09, 2012

BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for the quarter ended September 30, 2012 and provided an update on company operations.

Back to news